On the right to the cladogram, plasma total prostate specific antigen (PSA) levels are placed on the timeline in dark gray, together with corresponding percent free PSA values in light gray when available. GP5 received dutasteride and finasteride for symptoms of benign prostatic hyperplasia during...
Jamshidian H, Taherimahmoudi M, Ayati M. Prostate-specific antigen density and gleason score predict adverse pathologic features in patients with clinically localized prostate cancer. Nephrourol Mon Nephrourol Mon 2016; 8(6): e39984
Several studies have illustrated increased sensitivity for prostate-specific antigen (PSA) testing in men who undergo prostate massage before urine collection.7 This can lead to earlier detection of prostate cancer and greater chances of successful treatment. Erectile dysfunction There are nerves that con...
Prostate-specific antigen (PSA) levels have been used for detection and surveillance of prostate cancer (PCa). However, factors other than PCa—such as genetics—can impact PSA. Here we present findings from a genome-wide association study (GWAS) of PSA in 28,503 Kaiser Permanente whites and ...
Although the Food and Drug Administration recommends a prostate-specific antigen (PSA) threshold of 4 ng/dL as abnormal, investigations into the use of lower thresholds have shown substantial positive predictive value. The authors recommend that screening for prostate cancer begin at age 40 years. ...
A flow chart in this study workflow. PSA: prostate-specific antigen; PC: prostate cancer; DCE-MRI: dynamic contrast-enhanced MRI; DWI: diffusion-weighted imaging; PZ: peripheral zone; TZ: transition zone; PI-RADS: Prostate Imaging Reporting and Data System Full size image 2.6 Statistical analys...
To examine prostate-specific antigen (PSA) as a screening test in randomly selected primary care practices. Chart abstractions of a random selection of 552 men (age, > or = 50 years) and physician and practice-level surveys. Fifty-eight randomly selected, nonteaching, non-governmental, primary...
Clinical and pathological data were collected from their medical chart records. Performance status, body mass index, clinical symptoms, initial serum prostate-specific antigen (PSA), nadir PSA level (nPSA), and treatment modality were reviewed retrospectively. Statistical methods includ...
Prostate Specific Antigen (PSA) levels, Gleason Score, Pathological Tumor Stage (pT stage), and the expression level of circKIF18B_003. Age and Prostate Volume were included as general patient characteristics that could potentially influence the disease course. PSA levels, Gleason Score, and pT st...
Before performing prostate-specific antigen (PSA) screening in male populations, potential risks and benefits should be disclosed. Class I Recommendation Class II Recommendation Men > 50 years old should undergo PSA follow-up every 2 years. ...